Home LiteratureArticle Details
PMID: 7831291 Published · ppublish English Journal Article Research Support, Non-U.S. Gov't Research Support, U.S. Gov't, Non-P.H.S. Research Support, U.S. Gov't, P.H.S.

Targeting of a nuclease to murine leukemia virus capsids inhibits viral multiplication.

Natsoulis G, Seshaiah P, Federspiel MJ, Rein A, Hughes SH, Boeke JD

Abstract

Capsid-targeted viral inactivation is an antiviral strategy in which toxic fusion proteins are targeted to virions, where they inhibit viral multiplication by destroying viral components. These fusion proteins consist of a virion structural protein moiety and an enzymatic moiety such as a nuclease. Such fusion proteins can severely inhibit transposition of yeast retrotransposon Ty1, an element whose transposition mechanistically resembles retroviral multiplication. We demonstrate that expression of a murine retrovirus capsid-staphylococcal nuclease fusion protein inhibits multiplication of the corresponding murine leukemia virus by 30- to 100-fold. Staphylococcal nuclease is apparently inactive intracellularly and hence nontoxic to the host cell, but it is active extracellularly because of its requirement for high concentrations of Ca2+ ions. Virions assembled in and shed from cells expressing the fusion protein contain very small amounts of intact viral RNA, as would be predicted for nuclease-mediated inhibition of viral multiplication.

MeSH Terms
3T3 Cells Animals Antiviral Agents/metabolism Capsid/metabolism Gene Products, gag/genetics,metabolism,pharmacology Leukemia Virus, Murine/growth & development Mice Micrococcal Nuclease/genetics,metabolism,pharmacology RNA, Viral/metabolism Recombinant Fusion Proteins/metabolism,pharmacology Virion/growth & development Virus Replication
Chemicals
Antiviral Agents Gene Products, gag RNA, Viral Recombinant Fusion Proteins Micrococcal Nuclease
Authors & Affiliations
6 authors, click to expand affiliations / ORCID
Natsoulis G
Department of Molecular Biology and Genetics, Johns Hopkins University School of Medicine, Baltimore, MD 21205.
Seshaiah P
Federspiel M J
Rein A
Hughes S H
Boeke J D
References (17)
17 references, click to expand
  1. Reverse transcriptase encoded by a human transposable element.
    Science. 1991 Dec 20;254(5039):1808-10 PMID: 1722352
  2. Reverse transcriptase encoded by a retrotransposon from the trypanosomatid Crithidia fasciculata.
    Proc Natl Acad Sci U S A. 1991 Nov 1;88(21):9794-8 PMID: 1719539
  3. Phenotypes of murine leukemia virus-induced tumors: influence of 3' viral coding sequences.
    J Virol. 1992 Oct;66(10):6107-16 PMID: 1326661
  4. Rapid cell culture assay technic for murine leukaemia viruses.
    Nature. 1971 Feb 19;229(5286):564-6 PMID: 4925356
  5. Assembly of type C oncornaviruses: a model.
    Science. 1978 Jan 13;199(4325):183-6 PMID: 202022
  6. Effect of chemical modification and fragmentation on antigenic determinants of internal protein p30 and surface glycoprotein gp70 of type C retroviruses.
    J Virol. 1980 Mar;33(3):983-92 PMID: 6154154
  7. Isolation and properties of Moloney murine leukemia virus mutants: use of a rapid assay for release of virion reverse transcriptase.
    J Virol. 1981 Apr;38(1):239-48 PMID: 6165830
  8. Helper-independent retrovirus vectors with Rous-associated virus type O long terminal repeats.
    J Virol. 1988 Dec;62(12):4809-12 PMID: 2460645
  9. Adaptor plasmids simplify the insertion of foreign DNA into helper-independent retroviral vectors.
    J Virol. 1987 Oct;61(10):3004-12 PMID: 3041020
  10. Mutagenesis of the region between env and src of the SR-A strain of Rous sarcoma virus for the purpose of constructing helper-independent vectors.
    Virology. 1984 Jul 15;136(1):89-99 PMID: 6330999
  11. Incorporation of chimeric gag protein into retroviral particles.
    J Virol. 1990 Sep;64(9):4169-79 PMID: 2166812
  12. Transport and assembly of gag proteins into Moloney murine leukemia virus.
    J Virol. 1990 Nov;64(11):5306-16 PMID: 1698996
  13. Replication-competent retrovirus vectors for the transfer and expression of gene cassettes in avian cells.
    J Virol. 1991 Jul;65(7):3728-37 PMID: 2041092
  14. New antiviral strategy using capsid-nuclease fusion proteins.
    Nature. 1991 Aug 15;352(6336):632-5 PMID: 1650915
  15. Evidence that a downstream pseudoknot is required for translational read-through of the Moloney murine leukemia virus gag stop codon.
    Proc Natl Acad Sci U S A. 1991 Aug 15;88(16):6991-5 PMID: 1871115
  16. Form, function, and use of retroviral gag proteins.
    AIDS. 1991 Jun;5(6):639-54 PMID: 1883539
  17. Bipartite signal for read-through suppression in murine leukemia virus mRNA: an eight-nucleotide purine-rich sequence immediately downstream of the gag termination codon followed by an RNA pseudoknot.
    J Virol. 1992 Aug;66(8):5127-32 PMID: 1629968
Article Info
Journal
Proceedings of the National Academy of Sciences of the United States of America
Abbr.
Proc Natl Acad Sci U S A
ISSN
0027-8424
Published
1995-01-17
Pages
364-8
Language
English
Region
United States
NLM ID
7505876
PMCID
PMC42740
Subset
IM
Grants
NCI NIH HHS · N01-CO-74101 · United States
NCI NIH HHS · P01-CA16519 · United States
NIAID NIH HHS · U01-AI35282 · United States
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: [email protected]